Cross-interactions between the Alzheimer Disease Amyloid-β Peptide and Other Amyloid Proteins: A Further Aspect of the Amyloid Cascade Hypothesis
- PMID: 27325705
- PMCID: PMC4974365
- DOI: 10.1074/jbc.R116.714576
Cross-interactions between the Alzheimer Disease Amyloid-β Peptide and Other Amyloid Proteins: A Further Aspect of the Amyloid Cascade Hypothesis
Erratum in
-
Cross-interactions between the Alzheimer disease amyloid-β peptide and other amyloid proteins. A FURTHER ASPECT OF THE AMYLOID CASCADE HYPOTHESIS.J Biol Chem. 2017 Feb 3;292(5):2046. doi: 10.1074/jbc.A116.714576. Epub 2017 Feb 3. J Biol Chem. 2017. PMID: 28159759 Free PMC article. No abstract available.
Abstract
Many protein folding diseases are intimately associated with accumulation of amyloid aggregates. The amyloid materials formed by different proteins/peptides share many structural similarities, despite sometimes large amino acid sequence differences. Some amyloid diseases constitute risk factors for others, and the progression of one amyloid disease may affect the progression of another. These connections are arguably related to amyloid aggregates of one protein being able to directly nucleate amyloid formation of another, different protein: the amyloid cross-interaction. Here, we discuss such cross-interactions between the Alzheimer disease amyloid-β (Aβ) peptide and other amyloid proteins in the context of what is known from in vitro and in vivo experiments, and of what might be learned from clinical studies. The aim is to clarify potential molecular associations between different amyloid diseases. We argue that the amyloid cascade hypothesis in Alzheimer disease should be expanded to include cross-interactions between Aβ and other amyloid proteins.
Keywords: Alzheimer disease; amyloid; amyloid-beta (Aβ); cross-amyloid interaction; fibrillation; oligomer; oligomerization.
© 2016 by The American Society for Biochemistry and Molecular Biology, Inc.
Figures
References
-
- Lippa C. F., Fujiwara H., Mann D. M. A., Giasson B., Baba M., Schmidt M. L., Nee L. E., O'Connell B., Pollen D. A., St George-Hyslop P., Ghetti B., Nochlin D., Bird T. D., Cairns N. J., Lee V. M., et al. (1998) Short communication Lewy bodies contain altered α-synuclein in brains of many familial Alzheimer's disease patients with mutations in presenilin and amyloid precursor protein genes. Am. J. Pathol. 153, 1365–1370 - PMC - PubMed
-
- Huang H.-C., and Jiang Z.-F. (2009) Accumulated amyloid-β peptide and hyperphosphorylated tau protein: relationship and links in Alzheimer's disease. J. Alzheimers Dis. 16, 15–27 - PubMed
-
- Abelein A., Abrahams J. P., Danielsson J., Gräslund A., Jarvet J., Luo J., Tiiman A., and Wärmländer S. K. T. S. (2014) The hairpin conformation of the amyloid β peptide is an important structural motif along the aggregation pathway. JBIC J. Biol. Inorg. Chem. 19, 623–634 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
